A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2004
12/22/2004	EP1489071A1 N-substituted, 3,4-dihydro-1H-isoquinoline as potassium channels modulators
12/22/2004	EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders
12/22/2004	EP1488801A1 Chemical igf-i composition for the treatment and prevention of neurodegenerative diseases
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488231A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
12/22/2004	EP1488005A1 Histone deacetylase: novel molecular target of neurotoxicity
12/22/2004	EP1487998A2 Methods for diagnosing and treating schizophrenia
12/22/2004	EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487835A1 Amides of acetic and propionic acids
12/22/2004	EP1487834A1 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
12/22/2004	EP1487831A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
12/22/2004	EP1487829A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487822A2 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487817A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487811A1 N-sulfonylurea apoptosis promoters
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487804A2 Aminoindazole derivatives as protein-kinase inhibitors
12/22/2004	EP1487802A1 Neurotensin active 2,3-diaryl-pyrazolidine derivatives
12/22/2004	EP1487801A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487797A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols
12/22/2004	EP1487774A2 Bipolar trans carotenoid salts and their uses
12/22/2004	EP1487542A1 Use of asc-1 inhibitors to treat neurological and psychiatric disorders
12/22/2004	EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004	EP1487488A1 Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
12/22/2004	EP1487481A2 Methods of treating nerve entrapment syndromes
12/22/2004	EP1487480A2 Fusion molecules and methods for treatment of immune diseases
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto
12/22/2004	EP1487469A1 Co-beadlet of dha and rosemary and methods of use
12/22/2004	EP1487468A1 Plant extracts and the use thereof
12/22/2004	EP1487451A1 Inhibition of cell death responses induced by oxidative stress
12/22/2004	EP1487441A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
12/22/2004	EP1487431A1 Preventing and/or treating cardiovascular disease and/or associated heart failure
12/22/2004	EP1487429A2 Compositions of venlafaxine base
12/22/2004	EP1487428A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/22/2004	EP1487427A1 Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
12/22/2004	EP1487285A1 Alertness bar
12/22/2004	EP1487272A1 Choline-silicic acid complex with osmolytes and divalent trace elements
12/22/2004	EP1453949A4 Production of cell suspensions
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1363656B1 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
12/22/2004	EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1210103B1 Thrombopoietin for treatment of neurologic damage
12/22/2004	EP1169014B1 Antiperspirant compositions
12/22/2004	EP1140090B1 Use of phanquinone for the treatment or prevention of memory impairment
12/22/2004	EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004	EP1007043B9 Method for treatment of cns-involved lysosomal storage diseases
12/22/2004	EP0956026B1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
12/22/2004	EP0799045B2 Treatment of hyperexcited nerve cell functions
12/22/2004	CN1556810A Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
12/22/2004	CN1556809A Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
12/22/2004	CN1556808A Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosme
12/22/2004	CN1556805A Piperidine derivative as NMDA receptor antagonist
12/22/2004	CN1556804A 3-substituted-4-pyrimidone derivatives
12/22/2004	CN1556800A Process for the preparation of citalopram
12/22/2004	CN1556788A Muscarinic agonists
12/22/2004	CN1556720A Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
12/22/2004	CN1556716A Modular infusion device and method
12/22/2004	CN1556709A Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
12/22/2004	CN1556708A Methods for inhibiting cognitive deterioration in adults with down's syndrome
12/22/2004	CN1556706A Thieno [1,3] oxazin-4-ones with lipase inhibiting activity
12/22/2004	CN1556705A 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
12/22/2004	CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004	CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004	CN1556698A Neuroprotective treatment methods using selective iNOS inhibitors
12/22/2004	CN1555889A Cellar air health care therapeutic agent
12/22/2004	CN1555887A Mineral composition and its manufacturing method
12/22/2004	CN1555877A Brain nourishing memory strengthening additive of hair care liquid
12/22/2004	CN1555859A External compress Chinese medicinal ointment for treating facial paralysis and its preparation method
12/22/2004	CN1555855A Packaging material of composite suit medicine for comprehensive discriminate treating anypnia
12/22/2004	CN1555848A Chinese medicine for treating trigeminal neuralgia and its preparation method
12/22/2004	CN1555842A Chinese medicine for expelling stasis
12/22/2004	CN1555835A Medicinal pillow, health protection medicinal wine
12/22/2004	CN1555830A External use sticking-plaster for treating peripheral prosopoplegia
12/22/2004	CN1555811A Pearl lozenge
12/22/2004	CN1555809A Eyedrop powder for treating palsy
12/22/2004	CN1555805A Ortho diphenylhydratoin freeze dried powder for injection and its preparation method
12/22/2004	CN1555794A Orazitan dispersion tablet and its preparation method
12/22/2004	CN1181075C Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
12/22/2004	CN1181067C Benzofurans
12/22/2004	CN1181065C Aralkylformylakyl piperazine derivative and its application as brain nerve protector
12/22/2004	CN1181064C Process for preparing crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
12/22/2004	CN1181062C 2-phenoxy pyrimidine derivative and its use in treating disease
12/22/2004	CN1181059C Quinoline-4-base derivative I
12/22/2004	CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/22/2004	CN1180834C Drug for treating sciation and its preparing method
12/22/2004	CN1180822C Medicine for treating hemiparalysis, epilepsy, facial paralysis etc.
12/22/2004	CN1180803C Medicine for treating epilepsy
12/22/2004	CN1180789C Compound medicine for migraine
12/22/2004	CN1180788C Process for preparing heterogenous phaeochrome cell microcapsule
12/22/2004	CN1180725C Multielement calcium-rich liver-protecting sobering up beverage
12/21/2004	US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases

1 ... 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 ... 1833